baber/WOPTO huggingface dataset:
Patent AT-E163623-T1 (AT)
Inventor: BRUGGER FRANCOIS
IPC: B65D25/14
Filed: 1994-08-18
Granted: 1998-03-15
Abstract: The invention relates to an aerosol container for pharmaceutically active aerosols which are to be administered in specified quantities and are provided in the form of a suspension in the container, the suspension comprising at least a propellent gas in addition to a pharmaceutically active substance. The aerosol container (1) comprises a metering valve (2) which has a metering chamber (20) and a valve tube (21). In a first position of the valve tube, the metering chamber communicates with the interior of the container and is filled with a specified quantity of the aerosol. In a second position of the valve tube, it releases the quantity of the aerosol located in the metering chamber. The propellent gas is an alternative propellent gas which is free from chlorofluorocarbons, preferably a propellent gas comprising only fluorocarbons, and the inside wall of the container is plastic-coated. <IMAGE>
Patent AT-E143778-T1 (AT)
Inventor: MONTESI RICCARDO
IPC: A47B96/02
Filed: 1994-04-14
Granted: 1996-10-15
Abstract: The invention relates to an invisible support for fixing shelves to walls, comprising at least one horizontal element (2) insertable in a cavity (3) in a shelf (1), vertically constraining it to the support (6). The support (6) comprises at least one rawl (4), which can be hidden in the cavity (3) and which interacts between the horizontal element (2) and at least one wall (5) of the cavity (3) in such a way as to permit of free horizontal movement of the shelf (1) with respect to the support (6) only during a nearing operation, while preventing such movement in a retrograde direction. <IMAGE>
Patent AT-E163403-T1 (AT)
Inventor: FRANCZYK THADDEUS STEPHAN
IPC: C07C227/02
Filed: 1994-04-06
Granted: 1998-03-15
Abstract: PCT No. PCT/US94/03770 Sec. 371 Date Jan. 16, 1996 Sec. 102(e) Date Jan. 16, 1996 PCT Filed Apr. 6, 1994 PCT Pub. No. WO94/24091 PCT Pub. Date Oct. 27, 1994An improved process is discloses to prepare an amino carboxylic acid salt. According to the process an aqueous solution of an amino alcohol is contacted with an alkali metal hydroxide in the presence of an effective amount of Raney copper catalyst that has from about 10 parts per million of an element selected from the group consisting of bismuth, tin, antimony, lead, germanium and mixtures thereof.
Patent AT-E168836-T1 (AT)
Inventor: OAKLEY JOHN EDWARD
IPC: E05F15/10
Filed: 1994-09-22
Granted: 1998-08-15
Abstract: A drive assembly 10 for a power operated door comprises a DC motor 12 which is drivingly coupled to a torsion spring shaft assembly 13 of the door. The motor is controlled by a control circuit which includes a current sensing device and a microcontroller, the current sensing device causing disabling of the motor when a higher than expected current is sensed which is indicative of the fact that either the door has reached its fully opened or closed positions or has encountered an obstruction. The control circuit may comprise a MOSFET connected to a monitoring circuit which monitors the flow of current through the MOSFET. The drive assembly 10 may be powered via a backup DC power supply which is charged by an AC supply through a transformer. <IMAGE>
Patent AT-E174222-T1 (AT)
Inventor: GUGGENBICHLER JOSEF PETER PROF
IPC: C07H13/02
Filed: 1994-09-08
Granted: 1998-12-15
Abstract: The invention concerns a pharmaceutical preparation which contains one or several galacturonides as the active substance with a degree of polymerization of >/=2 and a degree of esterification of <20% optionally together with common pharmaceutical carriers, diluents, auxiliary substances and fillers as well as the use of this preparation to block the attachment of germs to mammalian cells.
Patent AT-E240991-T1 (AT)
Inventor: LIN NAN-JAE
IPC: B43K8/02
Filed: 1994-10-17
Granted: 2003-06-15
Abstract: A non-erasable liquid ink for a marking instrument including a colorant and a solvent and having a water content of about 0-15% by weight and a viscosity of about 15 to 4,500 cps. Also disclosed is a marking instrument filled with an ink of such a viscosity or lower in its reservoir.
Patent AT-E175621-T1 (AT)
Inventor: RIESSELMANN FRANZ-JOSEF
IPC: B29C53/48
Filed: 1995-06-28
Granted: 1999-01-15
Abstract: In a process for continuous prodn. of composite pipe comprising a metal pipe (18) and an inner plastic lining (10), the tubular plastic lining (10) has an initial OD greater than the ID of the metal pipe (18). The plastic pipe (10) is heated (12) and the OD reduced (14) below the ID of the metal pipe (18), before cooling to set the dia.. A metal band (20) is wrapped around the cooled plastic pipe (10) and formed into a metal pipe (18). After reheating the plastic pipe (10) the OD increases and the plastic pipe (10) presses against the inner wall of the metal pipe (18). <IMAGE>
Patent AT-E156052-T1 (AT)
Inventor: ARANTES ANTONIO CREMILDO
IPC: B23K9/29
Filed: 1995-03-23
Granted: 1997-08-15
Abstract: The automatic welding installation includes a robot arm with an assembly face (13) for welding torches held in a rack (21) and provided with an assembly face (47). The robot arm incorporates a locking/unlocking device (63-65) for welding torches, and is provided with means for supply of welding wire to these torches. The installation is characterised by the fact that the torches consist of a part (44) with the assembly face (47), and a movable nose-piece (40) which is connected to the part (44) and can be positionally adjusted by a distance control unit (45). Welding wire is supplied through a guide tube (43) consisting of two parts which are axially slidable relative to one another and are fixed respectively to the nose-piece (40) and the part (44) of the torch.
Patent AT-E192937-T1 (AT)
Inventor: BORGHI ENZO
IPC: A61N1/05
Filed: 1995-03-10
Granted: 2000-06-15
Abstract: The components of an adaptor device for use with pacemaker electrode catheters include a conductive element (5), typically a stilet, serving to ensure a sound connection between the already implanted spiral wound wire (1) and a new pacemaker (S): in the improved adaptor, the conductive element (5) is flexible, appearing as a further spiral wound wire secured by one end to a spindle (3) and extending from the tip of the spindle along the entire length of the implanted wire (1) so as to terminate near the stimulation electrode, which is anchored in a ventricular wall of the cardiac muscle. <IMAGE>
Patent AT-E157171-T1 (AT)
Inventor: MUNDILL PAUL HENRY CHARLES
IPC: G01N31/22
Filed: 1994-11-08
Granted: 1997-09-15
Abstract: An assay sample testing device comprises a porous liquid-permeable carrier strip within a casing, the carrier including a detection zone in which an assay result is revealed by specific binding of a detectable material directly or indirectly to a binding agent immobilised in the detection zone, the casing including internal registration means which cooperatively engages with corresponding registration means associated with the carrier, for example a pin and hole, such that said detection zone within the casing is precisely located in relation to the interlocking means on the casing. During manufacture, the corresponding registration means is used to control accurate formation of the detection zone on the carrier, and accurate placement of the carrier within the casing.
Patent AT-E173264-T1 (AT)
Inventor: KOJIMA YASUHIRO
IPC: A61K31/535
Filed: 1995-01-11
Granted: 1998-11-15
Abstract: PCT No. PCT/JP95/00025 Sec. 371 Date Nov. 29, 1996 Sec. 102(e) Date Nov. 29, 1996 PCT Filed Jan. 11, 1995 PCT Pub. No. WO95/19363 PCT Pub. Date Jul. 20, 1995This invention provides compounds of the following chemical formula or their pharmaceutically-acceptable salts:    <IMAGE>  (I)  wherein R is hydrogen or chloro. Also, the present invention provides a process for the production of the compound of formula I, which comprises cultivating a microorganism having the identifying characteristics of Aspergillus fischeri var. thermomutatis ATCC 18618 or the like, and then isolating the compound of formula I from the fermentation broth. The pyrrolobenzoxazine compounds of formula I of this invention have broad antiparasitic activity, and thus are useful as antiparasitic agents, especially as anthelmintics.
Patent AT-E173577-T1 (AT)
Inventor: MARTIN BARRY
IPC: A01C1/00
Filed: 1995-01-30
Granted: 1998-12-15
Abstract: An increase in the quality of maize seed, especially with respect to improved seed vigor, is achieved by defoliating maize plants during a specific period after pollination. A maize seed assemblage then is obtained that is characterized by an enhanced seed vigor.
Patent AT-E204414-T1 (AT)
Inventor: EATWELL GRAHAM P
IPC: G10K11/16
Filed: 1995-01-26
Granted: 2001-09-15
Abstract: An active control system for multiple interacting channels to control a constant noise or vibration consisting of first and second sensor means adapted to provide reference and residual signals respectively, a first and second filter means and first and second subtraction means to provide first and second output control signals and means for combining said output signals.
Patent AT-E172416-T1 (AT)
Inventor: DURCHSCHLAG GERALD
IPC: B61L5/00
Filed: 1995-06-21
Granted: 1998-11-15
Abstract: PCT No. PCT/AT95/00125 Sec. 371 Date Feb. 23, 1996 Sec. 102(e) Date Feb. 23, 1996 PCT Filed Jun. 21, 1995 PCT Pub. No. WO96/00160 PCT Pub. Date Jan. 4, 1996A device for operating switches includes a plurality of interlinked hydraulic switching devices (7) offset in the longitudinal direction of the rails. The first mechanical switching device is connected with a hydraulic cylinder/piston unit acting as a pumping element, the working volumes (13) of this first hydraulic cylinder/piston unit (7) acting as a pumping element being connected with the working volumes (13) of consecutive hydraulic cylinder/piston units (7) so as to be driven in same direction.
Patent AT-E189211-T1 (AT)
Inventor: LUM ROBERT T
IPC: C07D317/32
Filed: 1995-05-31
Granted: 2000-02-15
Abstract: The present invention describes compounds, methods and compositions effective to treat mast cell mediated inflammatory conditions, such as conjunctivitis, asthma and allergic rhinitis. The compounds of the invention comprise novel mono- and di-aminomethylbenzyl, aminobenzyl, guanidylbenzyl and benzyl tryptase inhibitors. The compositions for treating mast cell mediated inflammatory conditions include oral, inhalant and topical preparations as well as devices comprising such preparations.
Patent AT-E169375-T1 (AT)
Inventor: HITZIGER HUBERT
IPC: F01M1/02
Filed: 1995-09-18
Granted: 1998-08-15
Abstract: An internal combustion engine of the known type has an assembly support incorporating a lubricant oil pump and a coolant pump. Both pumps with their respective housings are mounted in apertures in the assembly support and sealed off from those apertures. A cover is then placed over the entire assembly support. The purpose of the invention is to produce an internal combustion engine in which the ancillary assemblies are easy to inspect and accessible. This is done by mounting the coolant pump (12) and oil pump (11) externally on the assembly support (10) and by providing at least one oil distributor channel (18) and coolant distributor channel (23) within the assembly support (10). This design ensures easy access to the ancillary assemblies.
Patent AT-E193140-T1 (AT)
Inventor: LESHEM PAWEL
IPC: G11B5/008
Filed: 1995-10-12
Granted: 2000-06-15
Abstract: A magnetic tape (2) and an apparatus (1) for cooperation with this magnetic tape (2) are configured in such a manner that video signals and audio signals can be stored in an inclined-track zone (67) and that a control signal (D-CTL signal) of a given frequency f1 can be stored in a first longitudinal track (24), which is, in fact, intended for recording analog audio signals, and that an additional control signal (X-CTL signal) of another frequency f2 can be stored in a second longitudinal track (26) on the magnetic tape (2), the additional control signal (X-CTL signal) being reproduced from the second longitudinal track (26) when such a magnetic tape (2) is loaded into a video recorder (1) in accordance with the VHS standard, or into a video recorder (1) in accordance with the invention, which is also capable of recording and reproducing analog video signals in accordance with the VHS standard in inclined tracks, which reproduced additional control signal is applied to a speed control device for a capstan, which results in a tape speed deviating from normal operation and precludes an undesirable signal reproduction.
Patent AT-E292173-T1 (AT)
Inventor: HERRMANN DIETER
IPC: A61K31/675
Filed: 1995-11-09
Granted: 2005-04-15
Abstract: A membranous enzyme not yet described in the state-of-the-art can be extracted from cellular membrane fractions of blood leukocytes or monocytes/macrophages. Also disclosed is the use of substrates of this enzyme to prepare medicaments that contain these substrates as pharmaceutical active substance. These medicaments are useful to direct pharmacologically active substances to target cells and to enrich target cells with said substances. Also disclosed are in-vitro research systems containing this enzyme used to detect other substrates of this enzyme.
Patent AT-E155036-T1 (AT)
Inventor: HINZ SABINE
IPC: A61K8/00
Filed: 1996-01-12
Granted: 1997-07-15
Abstract: A compsn. for washing the hair contains (a) an anionic, nonionic and/or zwitterionic surfactant, and (b) a mixt. of (i) at least 0.1 wt.% of lactic acid, (ii) at least 0.05% of citric acid and (iii) at least 0.05% of pyrrolidone carboxylic acid, all w.r.t. the total wt. of the compsn.
Patent AT-E239531-T1 (AT)
Inventor: HARSANYI OTTO
IPC: A63C5/07
Filed: 1996-03-02
Granted: 2003-05-15
Abstract: The ski binding cooperates with the underside of the ski boot, with the force applied by the skier received by an elongate relatively stiff carrier plate extending in the ski longitudinal direction. The carrier plate has a section which is rigidly secured to the ski (1) and a section which is spaced from the ski and coupled to it via a coupling with an elasticity and/or damping rate which is varied in dependence on detected parameters. Pref. the variable coupling is provided by at least one fluid-filled chamber (10,12) between the surface of the ski and the carrier plate.
Patent AT-E254033-T1 (AT)
Inventor: OHNO AKIHIKO OJI
IPC: B29C45/14
Filed: 1996-08-14
Granted: 2003-11-15
Abstract: An in-mold label which has a thermoplastic resin film base layer (I) having printed matter on its front side and, formed on the back side of the thermoplastic resin base layer (I), a heat sealable resin layer (II) having a lower melting point than the constituent resin of the thermoplastic resin film base layer (I), the constituent resin of the heat sealable resin layer (II) having as its main component an ethylene/ alpha -olefin copolymer obtained by copolymerizing from 40 to 98 wt% ethylene and from 60 to 2 wt% of an  alpha -olefin having from 3 to 30 carbon atoms using a metallocene catalyst.
Patent AT-E200596-T1 (AT)
Inventor: MCARDLE CIARAN BERNARD
IPC: H01F/
Filed: 1996-07-31
Granted: 2001-04-15
Abstract: The present invention discloses an anisotropically conductive film or a substrate having a surface covered with an anisotropically conductive coating, said film or coating being formed by solidification of a composition comprising: (i) a solidifiable ferrofluid composition, the ferrofluid comprising a ferromagnetic particle colloidal suspension in a non-magnetic carrier, and (ii) a plurality of electrically conductive particles dispersed in said ferrofluid, the electrically conductive particles having a non-random pattern arrangement by application of a substantially uniform magnetic field to the composition, in a liquid state, and being securely positioned by solidification of said composition. The composition is solidified in a step A of a process, which usually involves a primary curing. In a final use application of the particle or coating, the composition usually is subjected to a step B, or secondary curing. The film or substrate so coated is suitable as an article for the manufacture of joint conductors in the electrical industry.
Patent AT-E276783-T1 (AT)
Inventor: TWARDOWSKI ZBYLUT J
IPC: A61M1/14
Filed: 1996-01-31
Granted: 2004-10-15
Abstract: Blood is circulated through a multiple lumen catheter which connects between a vein of a patient and the blood treatment device. The catheter and the lumens thereof each define distal ends which are positioned within the vein. By this invention, one withdraws blood from the vein through one of the lumens at a flow rate of at least about 200 ml./min. while also inserting blood into the vein through another of said lumens at a similar flow rate. The distal ends of the lumens are longitudinally spaced from each other by no more than about 5 mm. It has been found that the following advantages can be achieved by this method: less clot formation coupled with low direct blood recirculation and longer catheter survival. Also, the catheter of this invention works well in either direction of blood flow through the respective lumens.
Patent AT-E206524-T1 (AT)
Inventor: HERMENTIN PETER
IPC: G01N30/86
Filed: 1996-05-30
Granted: 2001-10-15
Abstract: PCT No. PCT/EP96/02319 Sec. 371 Date Jan. 26, 1998 Sec. 102(e) Date Jan. 26, 1998 PCT Filed May 30, 1996 PCT Pub. No. WO97/05490 PCT Pub. Date Feb. 13, 1997The present invention involves a process for characterizing the glycosylation of glyco-proteins and an in vitro process for determining the bioavailability of glyco-proteins, based on the "hypothetical charge number" (or N) and usable for both endogenic and exogenic glyco-proteins.
Patent AT-E243526-T1 (AT)
Inventor: MCFADDEN GRANT
IPC: A61K38/00
Filed: 1996-04-19
Granted: 2003-07-15
Abstract: The present invention provides a method of use for a novel type I chemokine binding protein encoded by poxviruses and having amino acid sequence homology with the myxoma virus T7 interferon- gamma  receptor homolog against disease syndromes associated with acute or chronic dysregulated inflammatory responses.
Patent AT-E207054-T1 (AT)
Inventor: RINALDI MURIELLE
IPC: C07D295/08
Filed: 1996-06-20
Granted: 2001-11-15
Abstract: The use of human CB2 receptor-specific agonists of formula (I) or (I') for preparing immunomodulating drugs is disclosed. In formulae (I) and (I'), R1 is a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11, -CHR9CH2NR'6R'11, -(CH2)nZ and -COR8; R'1 is a -CH2CHR10NR6R11 or -(CH2)2NR'6R'11 group; R2 and R'2 are hydrogen, halogen or C1-4 alkyl; R3 is hydrogen, C1-4 alkyl or a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11 and -COR8; R'3 is a =CR6R8 group; R4 has one of the meanings given for R5 or is a -COR8 group; R5 is hydrogen, C1-4 alkyl, C1-4 alkoxy, a halogen atom, a CF3 group, an OCF3 group or C1-4 alkylthio; R'5 has one of the meanings given for R5 and is in the 5 or 6 position of the indene ring; R6 is hydrogen or C1-4 alkyl; R'6 is C1-4 alkyl; R7 has one of the meanings given for R5 or R7 and R9 together form a -Y-CH2- group attached to the indole ring in the 7 position by a group Y; R8 is phenyl substituted one to four times by a substituent selected from halogen, C1-4 alkyl or C1-4 alkoxy; a polycyclic ring selected from naphth-1-yl, naphth-2-yl, 1,2,3,4-tetrahydronaphth-1-yl, 1,2,3,4-tetrahydronaphth-5-yl, anthryl, benzofuryl, benzothien-2-yl, benzothien-3-yl, 2-, 3-, 4- or 8-quinolyl, said polycyclic rings optionally being substituted once or twice by a substituent selected from C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, halogen, cyano, hydroxyl, trifluoromethyl and imidazol-1-yl; R10 and R11 together are a group selected from -CH2-O-CH2-CR12R13- and -(CH2)p-CR12R13-, wherein the carbon atom substituted by R12 and R13 is attached to the nitrogen atom; R'11 is C1-4 alkyl; or R'11 and R'6, taken together with the nitrogen atom to which they are attached, form a group selected from morpholin-4-yl, thiomorpholin-4-yl, piperidin-1-yl and pyrrolidin-1-yl; each of R12 and R13 is independently hydrogen or C1-4 alkyl; n is 2, 3, 4 or 5; p is 2 or 3; Z is a methyl group or a halogen atom; and Y is a methylene group or an oxygen atom.
Patent AT-E230772-T1 (AT)
Inventor: ZUCCATO ALESSANDRO
IPC: A61L27/18
Filed: 1996-07-24
Granted: 2003-01-15
Abstract: A process of surface activation of a material based on one or more of the copolymers of lactic acid and  epsilon -caprolactone is carried out on bioabsorbable and biocompatible aliphatic polyesters chosen from the group formed by homo- and copolymers derived from L-lactide, D-lactide, racemic D,L-lactide, meso D,L-lactide,  epsilon -caprolactone, glycolide,  delta -valerolactone, p-dioxanone, preferably copolymers of L-lactide, D-lactide, racemic D,L-lactide, meso D,L-lactide with  epsilon -caprolactone; the process consists of performing at least one of the following treatments: acid or base hydrolysis, treatment by means of cold plasma, by chemical reactions or electromagnetic radiations. The process brings about a substantial increase in surface hydrophilicity and, consequently, a significant lowering of the wetting angle measured with water at 23 degrees Celsius in air. This can in many cases favour cellular adherence to bioabsorbable medical prostheses realised using these materials, and thus surface-activated, such as for example endothelialisation processes in vascular grafts.
Patent AT-E181888-T1 (AT)
Inventor: NOBLE PHILIPPE
IPC: B65D1/00
Filed: 1996-09-19
Granted: 1999-07-15
Abstract: A long-life polymeric packaging containing a fruit and/or vegetable beverage, and consisting of a single layer of methyl acrylate-acrylonitrile-butadiene terpolymer, is disclosed. A method for controlling the spoilage of fruit and/or vegetable beverages in a polymeric packaging, characterised in that said packaging consists of a single layer of methyl acrylate-acrylonitrile-butadiene terpolymer, is also disclosed.
Patent AT-E243998-T1 (AT)
Inventor: RUBINFELD JOSEPH
IPC: A61K31/565
Filed: 1996-09-27
Granted: 2003-07-15
Abstract: Liposome preparations which comprise a lipid, or lipid like compound and a 5beta steroid, DHEA or an organic acid derivative of the 5beta steroid or DHEA are described. The lipsome may also include an entraped aqueous portion which comprises dissolved therein the expression product of the ob gene. Methods for treating conditions including obesity,hypercorticoidism and diabetes using the liposome preparations are also claimed.
Patent AT-E179946-T1 (AT)
Inventor: DAVIES JON
IPC: B65D1/04
Filed: 1996-11-01
Granted: 1999-05-15
Abstract: The invention provides a container 10 comprising a wall defining at least one chamber and an opening 16a, 16b to the or each chamber. A cover member 19 comprising a body portion 20 and a closure member 24 is locatable on the wall so as to extend over the or each opening, and co-operating detent means 17, 28 on the wall and the body portion lock the body portion in position on the wall. The closure member 24 is frangibly attached to the body portion 20 whereby the closure member can only be opened by use of a tool, and is operable to sealingly close the or each opening 16a, 16b when the closure member is attached to the body portion and to reveal the or each opening when the closure member is broken away from the body portion.
Patent AT-E247856-T1 (AT)
Inventor: VON PIEVERLING KLAUS DR-ING
IPC: G08B25/00
Filed: 1997-09-18
Granted: 2003-09-15
Abstract: The system includes a message centre with associated danger notification sensors with a radio transceiver for the wireless danger-massage transmission to the message centre. The individual sensors do not transfer their message data directly to the message centre, during unfavourable radio wave propagation expansion conditions, but successively use one or several other sensors as relay stations for the transmission. The transmission path of a sensor over other sensors is preferably. chosen under consideration of a minimal attenuation of the radio field and/or a minimum number of intermediate stations, whereby the radio contact paths extend from the centre in a tree-like structure.